UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals Potential Anti-tumor Mechanism of Banxia Xiexin Decoction in Colorectal Cancer Mice

被引:0
|
作者
YUE Yinzi [1 ]
LI Mingxuan [2 ]
WANG Xiaohui [3 ]
QIN Yuanyuan [4 ]
WANG Yahui [5 ]
TAN Jinhua [3 ]
SU Lianlin [2 ]
YAN Shuai [5 ]
机构
[1] Department of General Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
[2] School of Pharmacy, Nanjing University of Chinese Medicine
[3] Department of General Surgery,Bayinguoleng Mongolian Autonomous Prefecture People's Hospital
[4] Department of Pharmacy, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine
[5] Department of Anorectal Surgery, Suzhou TCM Hospital Affiliated to Nanjing University of Chinese
关键词
D O I
暂无
中图分类号
R285 [中药药理学];
学科分类号
摘要
Objective: To clarify the potential mechanism of Banxia Xiexin Decoction(BXD) on colorectal cancer(CRC) from the perspective of metabolomics. Methods: Forty male C57BL/6 mice were randomly divided into normal control(NC), azoxymethane/dextran sulfate sodium(AOM/DSS) model, low-dose BXD(L-BXD), high-dose BXD(H-BXD) and mesalamine(MS) groups according to a random number table, 8 mice in each group. Colorectal cancer model was induced by AOM/DSS. BXD was administered daily at doses of 3.915(L-BXD) and 15.66 g/kg(H-BXD) by gavage for consecutive 21 days, and 100 mg/kg MS was used as positive control. Following the entire modeling cycle, colon length of mice was measured and quantity of colorectal tumors were counted. The spleen and thymus index were determined by calculating the spleen/thymus weight to body weight. Inflammatory cytokine and changes of serum metabolites were analyzed by enzyme-linked immunosorbent assay kits and ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry(UPLC-Q/TOF-MS), respectively. Results: Notably, BXD supplementation protected against weight loss, mitigated tumor formation, and diminished histologic damage in mice treated with AOM/DSS(P<0.05 or P<0.01). Moreover, BXD suppressed expression of serum inflammatory enzymes, and improved the spleen and thymus index(P<0.05). Compared with the normal group, 102 kinds of differential metabolites were screened in the AOM/DSS group, including 48 potential biomarkers, involving 18 main metabolic pathways. Totally 18 potential biomarkers related to CRC were identified, and the anti-CRC mechanism of BXD was closely related to D-glutamine and D-glutamate metabolism, phenylalanine, tyrosine and tryptophan biosynthesis, arginine biosynthesis, nitrogen metabolism and so on. Conclusion: BXD exerts partial protective effects on AOM/DSS-induced CRC by reducing inflammation, protecting organism immunity ability, and regulating amino acid metabolism.
引用
收藏
页码:623 / 632
页数:10
相关论文
共 50 条
  • [1] UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals Potential Anti-tumor Mechanism of Banxia Xiexin Decoction in Colorectal Cancer Mice
    Yue, Yin-zi
    Li, Ming-xuan
    Wang, Xiao-hui
    Qin, Yuan-yuan
    Wang, Ya-hui
    Tan, Jin-hua
    Su, Lian-lin
    Yan, Shuai
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (07) : 623 - 632
  • [2] UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals Potential Anti-tumor Mechanism of Banxia Xiexin Decoction in Colorectal Cancer Mice
    YUE Yinzi
    LI Mingxuan
    WANG Xiaohui
    QIN Yuanyuan
    WANG Yahui
    TAN Jinhua
    SU Lianlin
    YAN Shuai
    Chinese Journal of Integrative Medicine, 2024, (07) : 623 - 632
  • [3] UPLC-Q-TOF/MS-Based Serum Metabolomics Reveals the Anti-Ischemic Stroke Mechanism of Nuciferine in MCAO Rats
    Wu, Lanlan
    Chen, Chang
    Li, Yongbiao
    Guo, Cong
    Fan, Yuqing
    Yu, Dingrong
    Zhang, Tinglan
    Wen, Binyu
    Yan, Zhiyong
    Liu, An
    ACS OMEGA, 2020, 5 (51): : 33433 - 33444
  • [4] UPLC-Q-TOF/MS based fecal metabolomics reveals the potential anti-diabetic effect of Xiexin Decoction on T2DM rats
    Zhang, Zhi-Miao
    Chen, Meng-Jun
    Zou, Jun-Feng
    Jiang, Shu
    Shang, Er-Xin
    Qian, Da-Wei
    Duan, Jin-Ao
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2021, 1173
  • [5] UPLC-Q-TOF/MS-based urine metabolomics for the diagnosis and staging of bladder cancer
    Shi, Xingyu
    Zheng, Wenbin
    He, Binhong
    Huang, Longhui
    Zhong, Qisheng
    Yang, Yunfan
    Zhou, Ting
    Huang, Yong
    CLINICA CHIMICA ACTA, 2025, 565
  • [6] UPLC-Q-TOF/MS-Based Plasma and Urine Metabolomics Contribute to the Diagnosis of Sepsis
    Guan, Su
    Liu, Kun
    Liu, Zimeng
    Zhou, Liping
    Jia, Bingjie
    Wang, Zichen
    Nie, Yao
    Zhang, Xuyu
    JOURNAL OF PROTEOME RESEARCH, 2022, 21 (01) : 209 - 219
  • [7] Serum and urine metabolomics based on UPLC-Q-TOF/MS reveals the antipyretic mechanism of Reduning injection in a rat model
    Gao, Xia
    Huang, Chaojie
    Geng, Ting
    Chen, Xialin
    Wang, Jiajia
    Liu, Jingyin
    Duan, Kun
    Cao, Liang
    Wang, Zhenzhong
    Xiao, Wei
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 250
  • [8] UPLC-Q-TOF/MS-Based Metabolomics Approach Reveals Osthole Intervention in Breast Cancer 4T1 Cells
    Li, Xiuyun
    Zhang, Chenglun
    Wu, Enhui
    Han, Liang
    Deng, Xiangliang
    Shi, Zhongfeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [9] UPLC-Q-TOF/MS-based serum metabolomics revealed anti-tumor mechanism of ethanol-soluble acidic components from Camellia oleifera cake and synergy with PD-1 inhibitor
    Wang, Yixuan
    Yang, Songyu
    Chen, Shengbin
    Zuo, Yingbing
    Mu, Xiaoyu
    Zhou, Hongmei
    Yao, Yufei
    Peng, Xiaoping
    Li, Wenjuan
    FOOD BIOSCIENCE, 2025, 65
  • [10] UPLC-Q-TOF/MS-Based Metabolomics Approach to Reveal the Hepatotoxicity of Emodin and Detoxification of Dihydromyricetin
    Gao, Jian
    Shi, Ning
    Guo, Hongju
    Gao, Junfeng
    Tang, Xu
    Yuan, Siyuan
    Qian, Jiahui
    Wen, Binyu
    ACS OMEGA, 2021, 6 (08): : 5348 - 5358